Milestone Pharmaceuticals Inc. (MIST)
$1.27
$0.05
(4.10%)
As on 11-Jun-2026 16:28EDT
Market cap
$153 Mln
Revenue (TTM)
$2 Mln
P/E Ratio
--
P/B Ratio
4.4
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-2.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1.4
-
Debt to Equity
1.6
-
Book Value
$--
-
EPS
$-0.7
-
Face value
--
-
Shares outstanding
124,497,980
7 Years Aggregate
CFO
$-263.10 Mln
EBITDA
$-303.87 Mln
Net Profit
$-295.92 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Milestone Pharmaceuticals (MIST)
| -37.1 | -33.9 | -28.7 | -27.4 | -31.5 | -25.3 | -- |
|
BSE Sensex*
| -10.8 | -0.6 | -1.7 | -8.5 | 6.4 | 7.6 | 11.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|
|
Milestone Pharmaceuticals (MIST)
| -14.4 | -57.8 | -39.5 | -2.2 | -58.2 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Milestone Pharmaceuticals (MIST)
|
1.3 | 153.1 | 1.8 | -68.4 | -3,544.8 | -241.8 | -- | 4.4 |
| 5.3 | 1,716.2 | 79.2 | -144.0 | -259.5 | -15.1 | -- | 2.1 | |
| 15.9 | 2,037.1 | 298.3 | 298.2 | 47.7 | 63.9 | 7.3 | 3.7 | |
| 5.5 | 303.9 | 0.0 | -35.1 | 131,201.1 | -71 | -- | 6.4 | |
| 5.7 | 48.6 | 0.1 | -10.4 | -20,782.3 | -92.2 | -- | 34.6 | |
| 0.2 | 9.5 | 0.1 | -25.3 | -20,363.0 | -22.2 | -- | 0.1 | |
| 8.9 | 302.2 | 51.0 | -8.4 | -13.3 | -- | -- | 8.4 | |
| 1.6 | 5.2 | 663.9 | -9.9 | -1.5 | -86 | -- | 0.8 | |
| 52.2 | 5,000.5 | 0.0 | -383.2 | -- | -40.4 | -- | 3.7 | |
| 0.1 | 95.4 | 27.5 | -101.6 | -167.9 | -60.6 | -- | 0.3 |
Shareholding Pattern
View DetailsAbout Milestone Pharmaceuticals (MIST)
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the... conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada. Read more
-
CEO, President & Director
Mr. Joseph G. Oliveto M.B.A.
-
CEO, President & Director
Mr. Joseph G. Oliveto M.B.A.
-
Headquarters
Montreal, QC
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Milestone Pharmaceuticals (MIST)
What is the current share price of Milestone Pharmaceuticals Inc (MIST) Today?
The share price of Milestone Pharmaceuticals Inc (MIST) is $1.27 (NASDAQ) as of 11-Jun-2026 16:28 EDT. Milestone Pharmaceuticals Inc (MIST) has given a return of -31.49% in the last 3 years.
What is the current PB & PE ratio of Milestone Pharmaceuticals Inc (MIST)?
Since, TTM earnings of Milestone Pharmaceuticals Inc (MIST) is negative, P/E ratio is not available.
The P/B ratio of Milestone Pharmaceuticals Inc (MIST) is 4.42 times as on 05-Jun-2026, a 8 premium to its peers’ median range of 4.08 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-2.69
|
4.06
|
|
2024
|
-3.52
|
11.13
|
|
2023
|
-1.20
|
4.28
|
|
2022
|
-2.91
|
2.51
|
|
2021
|
-6.42
|
2.44
|
What is the 52 Week High and Low of Milestone Pharmaceuticals Inc (MIST)?
The 52-week high and low of Milestone Pharmaceuticals Inc (MIST) are Rs 3.06 and Rs 1.00 as of 12-Jun-2026.
What is the market cap of Milestone Pharmaceuticals Inc (MIST)?
Milestone Pharmaceuticals Inc (MIST) has a market capitalisation of $ 153 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Milestone Pharmaceuticals Inc (MIST)?
Before investing in Milestone Pharmaceuticals Inc (MIST), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.